The Impact of the Pathologic Differentiation (Well or Poorly) and the Degree of Ki-67 Index in Patients with Metastatic WHO Grade 3 GEP-NETs Abstract #1580

Introduction: There is few data for the treatment-outcome with etoposide plus platinum between well differentiated and poorly differentiated metastatic grade 3 GEP-NEC.
Aim(s): Herein, we investigated the impact of pathologic differentiation (well or poorly differentiation) in metastatic grade 3 GEP-NEC patients receiving etoposide and platinum based therapy.
Materials and methods: Herein, we investigated the impact of pathologic differentiation (well or poorly differentiation) in metastatic grade 3 GEP-NEC patients receiving etoposide and platinum based therapy.
Conference: 14th Annual ENETS conference (2017)
Category: Medical treatment - Others
Presenting Author: Seung Kim
Authors: Kim S, Park Y
Keywords: Ki67 index

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1852 Is Ki67 Index in Biopsy Tissue Truly Reflect Grading of Pancreatic Neuroendocrine Neoplasm?
Introduction: Ki67 index is essential for progression and treatment of pancreatic neuroendocrine neoplasm (pNEN). For advanced pNEN patient(pts), Ki67 scoring by core/fine-needle biopsy is used to evaluate pNEN pts’ grade.
Conference: 14th Annual ENETS conference (2017)
Category: Pathology, grading, staging
Presenting Author: Heli Gao
Authors: Gao H, Jin K, Wang W, Zhang S, ...
Keywords: pNEN, Ki67, biopsy, surgery
#1830 Increase of the Ki67 Proliferation Index over Time in Patients with Neuroendocrine Neoplasms
Introduction: Whether the Ki67 index increases over time in relation to progression is scarcely studied.
Conference: 14th Annual ENETS conference (2017)
Category: Pathology, grading, staging
Presenting Author: MD, PhD Pernille Holmager
#1693 A Better Ki-67 Index Cutoff to Redefine Low Grade NET and High Grade NEC in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms
Introduction: Heterogeneity of Grade 3 (G3) gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) was reported and well-differentiated G3 NET (neuroendocrine tumor) was classified by previous studies.
Conference: 14th Annual ENETS conference (2017)
Category: Pathology, grading, staging
Presenting Author: Jie Chen
Authors: Shi H, Chen L, Zhang Q, Han C, ...
#1286 A Comparative Analysis of Ki67 Index of the High Grade Neuroendocrine Neoplasms Arising in the Gastrointestinal Tract and the Pancreas
Introduction: A common classification has been used for NET in gastrointestinal tract (GI-NET) and pancreas (P-NET), but heterogeneity has been reported in high grade tumors; well-differentiated G3 (WDG3), poorly differentiated NEC (NEC), and mixed adenoneuroendocrine carcinoma (MANEC).
Conference: 13th Annual ENETS conference (2016)
Category: Pathology, grading, staging
Presenting Author: Atsuko Kasajima
#1116 Streptozotocin Based Chemotherapy in Advanced G2 Pancreatic Neuroendocrine Tumors (PNET): Efficacy According to KI67 Index
Introduction: Streptozotocin (STZ) with fluorouracil (FU) or doxorubicin (DOX) is approved in well differentiated advanced pancreatic neuroendocrine tumors (PNET).
Conference: 12th Annual ENETS Conference (2015)
Category: Medical treatment - Chemotherapy
Presenting Author: PhD Paula Jiménez-Fonseca
Close
Notice

WARNING – FRAUDULENT WEBSITES

ENETS is aware that its members have been confronted with fake websites, which seem to relate to our congress but have not been commissioned or authorised by us. The websites offer fraudulent hotel reservation services. We therefore strongly recommend that you please only use the official enetsconference.org website when booking your tickets and accommodation. Please be vigilant when it comes to providing your credit card details. 

If you have any questions, please do not hesitate to contact us at info@enets.org.